Developing new drugs isn’t easy. Only around 10% of compounds that reach preclinical development will ever be tested in a human being and for every drug that reaches the market, the company will have invested, on average, $359M and 12 years of their time.
This guide is designed to explain the work that goes on during those 12 years and how a company narrows down thousands of compounds into just one active pharmaceutical. We discuss the challenges involved in lead generation and preclinical development, what factors need to be considered during clinical trials, and how genomics has started to change the way we approach drug design.
Alongside our sponsors, we have tried to present you with a clear and unbiased look at the process of drug development. As with all our 101s, this guide is not intended to act as an instruction manual, but merely to introduce you to the topic and to highlight the major stages of pharmaceutical production. We hope that you find this guide to be interesting and, most importantly, useful.
A Product Manager with expertise in pharma marketing and sales operations